Surrogate endpoints in trials-a call for better reporting

被引:5
|
作者
Ciani, Oriana [1 ]
Manyara, Anthony M. [2 ]
Taylor, Rod S. [2 ,3 ]
机构
[1] SDA Bocconi Sch Management, Milan, Italy
[2] Univ Glasgow, Inst Hlth & Wellbeing, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland
[3] Univ Glasgow, Inst Hlth & Wellbeing, Robertson Ctr Biostat, Glasgow, Lanark, Scotland
来源
基金
英国医学研究理事会;
关键词
CLINICAL-TRIALS; PROTOCOL; STANDARD;
D O I
10.1136/bmj.o1912
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Biomarkers and surrogate endpoints in glaucoma clinical trials
    Medeiros, Felipe A.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (05) : 599 - 603
  • [22] Proof of principle trials: EEG surrogate endpoints
    Binnie, C
    EPILEPSY RESEARCH, 2001, 45 (1-3) : 7 - 11
  • [23] Surrogate endpoints in immunotherapy trials for solid tumors
    Petrelli, Fausto
    Ghidini, Michele
    Costanzo, Antonio
    Rampulla, Valentina
    Varricchio, Antonio
    Tomasello, Gianluca
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (07)
  • [24] Surrogate endpoints in pulmonary arterial hypertension trials
    Hoeper, Marius
    LANCET RESPIRATORY MEDICINE, 2023, 11 (10): : 852 - 853
  • [25] Incorporating surrogate endpoints into group sequential trials
    Cook, RJ
    Farewell, VT
    BIOMETRICAL JOURNAL, 1996, 38 (01) : 119 - 130
  • [26] A perspective on surrogate endpoints in controlled clinical trials
    Molenberghs, G
    Burzykowski, T
    Alonso, A
    Buyse, M
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2004, 13 (03) : 177 - 206
  • [27] Analysis and reporting of stratified cluster randomized trials-a systematic survey
    Borhan, Sayem
    Papaioannou, Alexandra
    Ma, Jinhui
    Adachi, Jonathan
    Thabane, Lehana
    TRIALS, 2020, 21 (01)
  • [28] Outcome switching in randomized controlled oncology trials reporting on surrogate endpoints: a cross-sectional analysis
    Alberto Falk Delgado
    Anna Falk Delgado
    Scientific Reports, 7
  • [29] Outcome switching in randomized controlled oncology trials reporting on surrogate endpoints: a cross-sectional analysis
    Delgado, Alberto Falk
    Delgado, Anna Falk
    SCIENTIFIC REPORTS, 2017, 7
  • [30] Are better endpoints and better design of clinical trials needed?
    Fransen, J
    van Riel, PLCM
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2004, 18 (01): : 97 - 109